Multidrug resistance in chronic myeloid leukaemia: how much can we learn from MDR–CML cell lines?

por Rumjanek, Vivian M., Vidal, Raphael S., Maia, Raquel C.
Publicado 2013

Ouabain inhibits monocyte activation in vitro: prevention of the proinflammatory mCD14(+)/CD16(+) subset appearance and cell-size progression

por Valente, Raphael C, Araujo, Elizabeth G, Rumjanek, Vivian M
Publicado 2012

Metabolic Reprogramming During Multidrug Resistance in Leukemias

por Vidal, Raphael Silveira, Quarti, Julia, Rumjanek, Franklin D., Rumjanek, Vivian M.
Publicado 2018

Towards Comprehension of the ABCB1/P-Glycoprotein Role in Chronic Myeloid Leukemia

por Maia, Raquel C., Vasconcelos, Flavia C., Souza, Paloma S., Rumjanek, Vivian M.
Publicado 2018

Corrigendum: Metabolic Reprogramming During Multidrug Resistance in Leukemias

por Vidal, Raphael Silveira, Quarti, Julia, Rodrigues, Mariana Figueiredo, Rumjanek, Franklin D., Rumjanek, Vivian M.
Publicado 2018

Selective Cytotoxicity of Piperine over Multidrug Resistance Leukemic Cells

por Quarti, Julia, Torres, Daianne N. M., Ferreira, Erika, Vidal, Raphael S., Casanova, Fabiana, Chiarini, Luciana B., Fialho, Eliane, Rumjanek, Vivian M.
Publicado 2021

Detachment of Hexokinase II From Mitochondria Promotes Collateral Sensitivity in Multidrug Resistant Chronic Myeloid Leukemia Cells

por Oliveira, Thaís, Lemos, Douglas, Jean, Louise, Kawashima, Jéssica M., de Azevedo, Vitória R., Salustiano, Eduardo J., Rumjanek, Vivian M., Monteiro, Robson Q.
Publicado 2022